Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 22, 2025 08:00 ET | Source: BioCardia, Inc.

BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure

SUNNYVALE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
September 19, 2025 07:45 ET | Source: Alvotech

Markaðsleyfi veitt í Japan fyrir þrjár nýjar líftæknilyfjahliðstæður frá Alvotech

REYKJAVÍK 19. september 2025 - Alvotech (NASDAQ: ALVO, ALVO-SDB) tilkynnti í dag að japanska heilbrigðis-, atvinnu- og velferðarráðuneytið hafi veitt Fuji Pharma Co. Ltd. („Fuji Pharma“),...
September 19, 2025 07:45 ET | Source: Alvotech

Alvotech Announces Marketing Approval in Japan of Three New Biosimilars

REYKJAVIK, ICELAND (September 19, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today...
September 19, 2025 07:45 ET | Source: Alvotech

Alvotech Announces Marketing Approval in Japan of Three New Biosimilars

REYKJAVIK, Iceland, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...
September 03, 2025 16:30 ET | Source: Japan Smaller Capitalization Fund

Japan Smaller Capitalization Fund, Inc. Announces Annual Meeting of Shareholders

Japan Smaller Capitalization Fund, Inc. Announces Annual Meeting of Shareholders
August 06, 2025 09:03 ET | Source: BTCC Exchange

BTCC Exchange Sets Sail for Exclusive Tokyo Summer Festival 2025 Aboard Traditional Yakatabune

BTCC hosts exclusive Tokyo Summer Festival aboard traditional yakatabune on Aug 24, plus lists CAW token Aug 8 to its list of 300+ trading pairs.
August 04, 2025 06:00 ET | Source: BioCardia, Inc.

BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter

SUNNYVALE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
July 24, 2025 09:00 ET | Source: BioCardia, Inc.

BioCardia Submits Request for Clinical Data Review Meeting with Japan PMDA To Discuss Approval Pathway for CardiAMP® Cell Therapy in Ischemic Heart Failure

SUNNYVALE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
June 06, 2025 18:15 ET | Source: Japan Smaller Capitalization Fund

Japan Smaller Capitalization Fund, Inc. Announces Initiatives to Enhance Shareholder Value

Japan Smaller Capitalization Fund , Inc. Announces Initiatives to Enhance Shareholder Value
March 10, 2025 09:15 ET | Source: BioCardia, Inc.

BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System

SUNNYVALE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...